Actinogen Medical (ASX:ACW) has this week enrolled its 100th participant for its “pivotal” XanaMIA phase 2b/three trial for ...

Among members of the Richardson family who carry a mutation in the PSEN1 gene, the average age when symptoms start is 39.

For years, researchers have seen a connection between exercise and the progression of cognitive disorders such as Alzheimer's ...

A once-a-day pill that could completely revolutionise the treatment of Alzheimer’s disease has reached a significant ...

Tulane University researchers created a first-of-its-kind subcellular map of an area of the brain commonly affected by ...

Recent research highlights carnosic acid, found in rosemary and sage, as a potential weapon against Alzheimer's. Scientists ...

Dr. Charles Bernick, a neurologist with the Cleveland Clinic, says this blood test can help with early diagnosis, giving people a chance to start treatment sooner. The earlier the treatment begins, ...

The experts agreed that carnosic acid could potentially improve the inflammation that generally occurs in most aging brains. There are cautions however.

Diagnosing Alzheimer’s is difficult, and precise biomarkers are needed to assist physicians in making accurate assessments, ...

NASA satellite emits 'spark' decades after going dormant: Astronomers think they know why California Gov. Newsom sues Fox ...

After decades of research, the U.S. Food and Drug Administration (FDA) has approved a test that can detect the buildup of ...

INmune Bio is working on a drug for Alzheimer's, with a critical phase 2 readout to be announced. Click here to find out why ...